Summary
A critical analysis has been performed of reports published on the incidence of gastro-intestinal (GI) side-effects found in arthritic patients being treated with non-steroid anti-inflammatory (NSAI) drugs. The results show the following:
-
1.
The incidence of GI ulceration (as revealed by gastroscopy) and haemorhage in arthritic patients taking NSAI drugs may be higher than suspected from clinical trial data.
-
2.
Incidence of all GI side-effects (including ulceration and haemorrhage) may be lower with some of the new NSAI drugs than with traditional drugs (e.g. aspirin, indomethacin and phenylbutazone).
-
3.
Arthritic patients may be more susceptible to the ulcerogenic actions of NSAI drugs. Experiments with animals, together with evidence from clinical studies, indicate that stress factors and the presence of decreased mucosal resistance in the diseased state may contribute to the enhanced susceptibility of the GI tract towards the ulcerogenicity of NSAI drugs.
-
4.
Comparison of data on gastroscopic observations in man with the author's data on the effects of NSAI drugs in stress-sensitized rats shows the latter technique appears to be a useful means of predicting the ulcerogenic potential of NSAI drugs in man. The comparison has also been used to predict the ulcerogenicity of drug — alcohol combinations; alcohol being a common ulcerogen consumed by many patients. Some NSAI drugs with low ulcerogenic activity (i.e. azapropazone, benoxaprofen and fenclofenac) in the stressed-rat assay show little or no interaction with alcohol.
These studies using laboratory animals show the importance of employing conditions to mimic environmental factors (e.g. stress and alcohol consumption) which might predispose individuals to ulcerogenic or other side-effects of NSAI drugs. From these studies it appears possible to construct ‘predictive profiles’ of the relative ulcerogenicity of NSAI drugs which may be applicable to the clinical situation in man.
Similar content being viewed by others
References
O'Brien WM (1968) Indomethacin: a survey of clinical trials. Clin Pharmacol Ther 9:94–107
Blechman WJ, Smid FR, April PA, Wilson CH, Brooks CD (1975) Ibuprofen aspirin in rheumatoid arthritis therapy. J Am Med Assoc 233:336–340
Sigler JW, Ridolfo AS, Bluhm GB (1976) Comparison of the benefit-to-risk ratios of aspirin and fenoprofen: controlled multicentre study in rheumatoid arthritis. J Rheumatol (Suppl 2) 3:49–60
Ciccolunghi SN, Chaudri HA, Schubiger BI, Reddrop R (1978) Report on a long-term tolerability study of up to two years with diclofenac sodium (Voltaren). Scand J Rheumatol (Suppl) 22:86–96
Melton JW, Lussier A, Ward JR, Neustadt D, Multz C (1978) Naproxen in osteo-arthritis of the hip and knee. J Rheumatol 5:338–346
Pitts NE, Proctor RR (1978) Summary: Efficacy and safety of piroxicam. In: O'Brien WM, Wiseman EH (eds) Piroxicam. Royal Society of Medicine/Academic Press, London, pp 97–108
Davis JD, Struth AG, Turner RA, Pisko EJ, Ruchte IR (1979) Pirprofen and aspirin in the treatment of rheumatoid arthitis. Clin Pharmacol Ther 25:618–623
Mikulaschek WM (1980) Long-term safety of benoxaprofen. J Rheumatol (Suppl 6) 7:100–107
Lanza F, Shah PN, Dalal NJ, Wagholikar UN, Pispati PK (1975) An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosa. Gastrointest Endosc 21:103–105
Silvoso GR, Ivey KJ, Butt JH, Lockard OO, Holt SD, Sisk C, Baskin WN, Mackercher PA, Hewitt J (1979) Incidence of gastric lesions in patients with rheumatic diseases on chronic aspirin therapy. Ann Intern Med 91:517–520
Caruso I, Porro GB (1980) Gastroscopic evaluation of anti-inflammatory agents. Br Med J 1:75–78
Cuthbert MF (1974) Adverse reactions to non-steroid antirheumatic drugs. Curr Med Res Opin 2:600–609
Fowler PD, Faragher EB (1977) Drug and non-drug factors influencing adverse reactions to pyrazoles. J Int Med Res (Suppl 2) 5:108–120
Sperling IL (1969) Adverse reactions with long-term use of phenylbutazone and oxyphenylbutazone. Lancet II:535–537
Bower RJ, Umbenhauer ER, Hercus V (1979) Clinical evaluation of sulindac: A new non-steroidal anti-inflammatory drug. In: Weissman G, Samuelsson B, Paoletti R (eds) Advances in Inflammation Research, vol 1. Raven Press, New York, pp 559–567
Huskisson EC, Williams TN, Shaw LD, Kerry J (1978) Diflunisal in general practice. Curr Med Res Opin 5:589–592
Pavelka K, Vojtisek O, Bremova A, Kankova D, Handlova D (1973) Double-blind comparison of alclofenac and phenylbutazone in the short-term treatment of rheumatoid arthritis. Curr Med Res Opin 1:342–350
Hingorini K (1976) A comparative study of azapropazone and ibuprofen in the treatment of osteo-arthritis of the knee. Curr Med Res Opin 4:57–64
Lassus A (1976) A comparative pilot study of azapropazone and indomethacin in the treatment of psoriatic arthritis and Reiter's disease. Curr Med Res Opin 4:65–69
Thune S (1976) A comparative study of azapropazone and indomethacin in the treatment of rheumatoid arthritis. Curr Med Res Opin 4:70–75
Akyol MS, Anderson M, Thompson M (1977) Fenclofenac in the treatment of rheumatoid arthritis and ankylosing spondylitis. Proc R Soc Med (Suppl 6) 70:37–39
Salter RH (1968) Aspirin and gastrointestinal bleeding. Am J Dig Dis 13:38–58
Hill HFH, Hill AGS (1977) Fenclofenac and soluble aspirin in rheumatoid arthritis: a comparative trial. Proc R Soc Med (Suppl 6) 70:27–30
Hingorani K (1977) Fenclofenac therapy in rheumatic diseases. Proc R Soc Med (Suppl 6) 70:40–42
Loebl WY (1977) Fenclofenac in rheumatoid arthritis — comparative studies. Proc R Soc Lond (Suppl 6) 70:31–33
Rooney PJ, Watkins C, Ahola SJ, Gray GIL, Dick WC (1976) A short-term double-blind controlled trial of prenazone (DA 2370) in rheumatoid arthritis. Curr Med Res Opin 2:43–50
Billings R, Burry HC, Grahame R, Betty DJ, Donovan B (1975) A double-blind cross-over trial of prenazone and aspirin in the management of rheumatoid arthritis. Rheumatol Rehabil 14:61–66
Collins RM, El-Chobarey AF, Bain LS, Donovan B (1975) The treatment of rheumatoid arthritis. A report on feprazone. Clin Trials J 1:25–30
Fletcher MR, Loebl W, Scott JT (1975) Feprazone, a new anti-inflammatory agent. Studies on potency and gastrointestinal tolerance. Ann Rheum Dis 34:190–194
Reynolds PMG, Sturrock RD, Isaacs A, Hart FD (1975) A double-blind cross-over trial of prenazone (DA2370) and phenylbutazone in rheumatoid arthritis. Rheumatol Rehabil 14:67–70
Sturrock R, Isaacs A, Hart FD (1975) Feprazone compared with indomethacin in the management of rheumatoid arthritis. Practitioner 215:94–97
Haslock I, Brukinshaw L, Berry DJ, Donovan B, Wright V (1976) Some studies on feprazone. Rheumatol Rehabil 15:81–86
Rooney PJ, McLeod M, Grennan DM, Dick WC (1976) Feprazone (DA2370): long-term experience in the management of rheumatoid arthritis complicated by severe dyspepsia. Curr Med Res Opin 3:642–646
Bain LS, Lynch MP, Bruce GM (1977) A double-blind trial of feprazone in osteo-arthritis of the hip. Curr Med Res Opin 4:665–669
Harkness AJL, Burr HC, Grahame R (1977) A Trial of feprazone in ankylosing spondylitis. Rheumatol Rehabil 16:158–161
Brewis IDL (1977) A comparative study of flurbiprofen and indomethacin in rheumatoid arthritis. Curr Med Res Opin 5:48–52
Cardoe N (1977) A double-blind cross-over study to compare the efficacy of three dosage levels of flurbiprofen in the treatment of rheumatoid disease and osteo-arthritis. Curr Med Res Opin 5:99–105
Franco PA, Ferri S, DiMummo O (1977) Controlled clinical trial comparing flurbiprofen and phenylbutazone in patients with rheumatoid arthritis. Curr Med Res Opin 5:74–76
Frank O (1977) A double-blind comparative study of 150 mg flurbiprofen daily and 75 mg indomethacin daily in the treatment of osteo-arthritis of the hip. Curr Med Res Opin 5:91–98
Hazelman BL, Bulgen DY (1977) A comparative study of the long-term efficacy of flurbiprofen and indomethacin in the treatment of rheumatoid arthritis, with special reference to iron metabolism. Curr Med Res Opin 5:58–63
Siegmuth W (1977) A comparative study of flurbiprofen and indomethacin in rheumatoid arthritis. Curr Med Res Opin 5:64–73
Sheldrake FE, Webber JM, Marsh BD (1977) A long-term assessment of flurbiprofen. Curr Med Res Opin 5:106–116
Royer GL, Moxley TE, Hearron MS, Miyara A, Donovan JF (1975) A six-month double-blind trial of ibuprofen and indomethacin in osteo-arthritis. Curr Ther Res 17:234–248
Polderman J, Colon M (1980) General practitioners' evaluation of side-effects and efficacy of oxamethacin as compared with indomethacin. J Int Med Res 8:156–162
Emanueli A, Mandelli V, Mascellani G, Sacchetti G (1979) Indoprofen, a non-steroidal anti-inflammatory drug, in the treatment of osteo-arthritis: report on a multicentre study in 1629 patients. Curr Med Res Opin 6:124–134
Goulton J, Baker PG (1980) Ketoprofen (‘orudis’) in the treatment of inflammatory arthritic conditions: a multicentre study in general practice. Curr Med Res Opin 6:423–430
Katona G (1977) Long-term tolerance and efficiency study with naproxen — 6 1/2 years of experience. Drugs Exp Clin Res 2:57–66
Huskisson EC, Berry H, Scott J, Balme HW (1974) Tolectin for rheumatoid arthritis. Rheumatol Rehabil 13:132–134
Berkowitz SS, Bernhard G, Bilka PJ, Blechman WJ, Marchesano JM, Rosenthale M, Worthams GF (1974) Tolmetin versus placebo for the treatment of rheumatoid arthritis: a sequential double-blind clinical trial. Curr Ther Res 16:442–451
Rainsford KD (1975) A synergistic interaction between aspirin or other non-steroid anti-inflammatory drugs, and stress which produces severe gastric mucosal damage in rats and pigs. Agents Actions 5:553–558
Ivey KJ, Silvoso GR, Krause WJ (1978) Effect of paracetamol on gastric mucosa. Br Med J 1:1586–1588
Seegers AJM, Jager LP, Noordwijk J Van (1978) Gastric erosions induced by analgesic drug mixtures in the rat. J Pharm Pharmacol 30:84–87
Trewby PN (1980) Drug-induced peptic ulcer and upper gastro-intestinal bleeding. Br J Hosp Med 23:185–188
Sun DCH, Roth SH, Mitchell CS, Englund DW (1974) Upper gastro-intestinal disease in rheumatoid arthritis. Am J Dig Dis 19:405–410
Ivey KJ, Clifton JA (1974) Back diffusion of hydrogen ions across gastric mucosa of patients with gastric ulcer and rheumatoid arthritis. Br Med J 1:16–19
Haslock I, Wright V (1974) Arthritis and intestinal disease. J R Coll Physicians (Lond) 8:154–162
Gullberg R (1978) Possible role of alterations of the intestinal flora in rheumatoid arthritis. Rheumatol Rehabil (Suppl) 1978:5–8
Svartz N (1972) The primary cause of rheumatoid arthritis is an infection — the infectious agent exists in milk. Acta Med Scand 192:231–239
Kent TH, Cardelli RM, Stamler FW (1969) Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol 54:237–249
Robert A, Asano T (1979) Resistance of germ-free rats to indomethacin-induced intestinal lesions. Prostaglandins 14:333–341
Sodato P Del, Meili A (1978) Studies on the mechanism of fat-free diet (FFD) protection against indomethacin-induced intestinal ulcers. Proc Soc Exp Biol Med 158:19–22
Pasquale G Di, Welaj P (1973) Ulcerogenic potential of indomethacin in arthritic and non-arthritic rats. J Pharm Pharmacol 25:831–832
Shriver DA, Dove PA, White CB, Sandor A, Rosenthale ME (1977) A profile of the gastro-intestinal toxicity of aspirin, indomethacin, oxaprozen, phenylbutazone, and fentiazic in arthritic and normal lewis rats. Toxicol Appl Pharmacol 42:75–83
Rainsford KD (1978) The role of aspirin in gastric ulceration. Some factors involved in the development of gastric mucosal damage induced by rats exposed to various stress conditions. Am J Dig Dis 23:521–530
Rainsford KD (1982) Effects of anti-inflammatory drugs on mucus production: relationship to ulcerogenesis. In: Pfeiffer CJ (ed) CRC handbook: Drugs and peptic ulcer disease, vol 2. CRC Press, West Palm Beach, FL (in press)
Morton DM, Chatfield DH (1970) The effect of adjuvantinduced arthritis on the liver metabolism of drugs in rats. Biochem Pharmacol 19:473–481
Whitehouse MW, Beck FJ (1973) Impaired drug metabolism in rats with adjuvant-induced arthritis: A brief review. Drug Metab Dispos 1:251–255
Barritt GJ, Whitehouse MW (1977) Pathobiodynamics: Effect of extrahepatic inflammation on calcium transport and drug metabolism by rat liver mitochondria in vitro. Biochem Med 17:99–115
Poon PYN, Whitehouse MW (1978) Changes in ascorbate metabolism in rats with peripheral inflammation. Biochem Med 20:81–86
Rooney PJ, Kennedy AC, Gray GH, Sturrock RD, Buchanan KD, Dick WC (1976) Serum immunoreactive gastrin (IRG) in rheumatoid arthritis: further observations on its identity, clinical specificity and relationship to gastric function. Ann Rheum Dis 35:246–250
Rooney PJ, Dick WC, Imrie RC, Turner D, Buchanan KD, Ardill J (1978) On the relationship between gastrin, gastric secretion, and adjuvant arthritis in rats. Ann Rheum Dis 37:432–435
Bergstrom K, Havermark G (1976) Enzymes in intestinal mucosa from patients with rheumatic diseases. Scand J Rheumatol 5:29–32
Ballantyne FC, Fleck A, Dick WC (1971) Albumin metabolism in rheumatoid arthritis. Ann Rheum Dis 30:265–270
Piafsky KM (1980) Disease-induced changes in the plasma binding of basic drugs. Clin Pharmacokinet 5:246–262
Menwissen SGM, Dekker-Saeys BJ, Agenant D, Tytgat GNJ (1978) Ankylosing spondylitis and inflammatory bowel disease I. Prevalence of inflammatory bowel disease in patients suffering from ankylosing spondylitis. Ann Rheum Dis 37:30–32
Enlow RW, Bias WB, Arnett FC (1980) The spondylitis of inflammatory bowel disease. Evidence for a non-HLA linked axial arthropathy. Arthritis Rheum 23:1359–1365
Clarke AK, Galbraith RM, Hamilton EDB, Williams R (1978) Rheumatic disorders in primary biliary cirhosis. Ann Rheum Dis 37:42–47
Simila S, Kokkonen J, Kaski M (1978) Achlasia sicca — Juvenile Sjogren's syndrome with achlasia and gastric hyposecretion. Eur J Pediatr 129:175–181
Miert ASJPAM Van (1980) Fever and gastric function. In: Lipton JM (ed) Fever. Raven Press, New York, pp 57–70
Selye H, Bajusz E (1966) Stress and rheumatic diseases. In: Hollander JL (ed) Henry Kimpton, New York, pp 618–630
King SH (1955) Psychological factors associated with rheumatoid arthritis. Evaluation of literature. J Chronic Dis 2:287–302
Moos RH, Solomon GF (1965) Psychological comparisons between women with rheumatoid arthritis and their nonarthritic sisters. I. Personality test and interview rating data. Psychosom Med 27:135–149
Shochet BR, Lisansky ET, Shubart AF, Fiocco V, Kurland S, Pope M (1969) A medical-psychiatric study of patients with rheumatoid arthritis. Psychosomatics 10:271–279
Solomon GF, Moos RH (1964) Emotions, immunity and disease. A speculative theoretical integration. Arch Gen Psychiatry 11:657–674
Hendrie HC, Paraskevas F, Baragar FD, Adamson JD (1971) Stress, immunoglobulin levels and early polyarthritis. J Psychosom Res 15:337–342
Ackerman SH (1975) Restraint ulceration as an experimental model. Psychosom Med 37:4–7
Allen HM (1972) Gastro-intestinal erosions in wild rats subjected to social stress. Life Sci 11:351–356
Moody FG, Cheungly, Simons MA, Zalwesky C (1976) Stress and the acute gastric mucosal lesion. Am J Dig Dis 21:148–154
Brodie DA, Hanson HM (1960) A study of the factors involved in the production of gastric ulcers by the restraint technique. Gastroenterology 38:353–360
Allen HM (1972) Gastro-intestinal erosions in wild rats subjected to ‘social stress’. Life Sci 11:351–356
Goodman AA, Osborne MP (1973) Stress ulcer. A definition, a discussion of other stress-associated upper gastro-intestinal lesions, and an experimental model. Am J Surg 125:461–463
Rainsford KD (1977) Comparative gastric ulcerogenic activities of non-steroid anti-inflammatory drugs. Agents Actions 7:573–577
Rainsford KD (1977) Gastro-intestinal damage from aspirin and non-steroid anti-inflammatory drugs: Thoughts for safer therapy from biochemical studies. Drugs Clin Res 2:121–132
Rainsford KD (1980) Comparison of the gastric ulcerogenic activity of anti-inflammatory drugs in pigs and stress-sensitized rats. Tissue Reactions 4:51–55
Rainsford KD, Whitehouse MW (1980) Biochemical gastroprotection from acute ulceration induced by aspirin and related drugs. Biochem Pharmacol 29:1281–1289
Grossman MI, Matsumoto KK, Lichter RJ (1961) Fecal blood loss produced by oral and intravenous administration of various salicylates. Gastroenterology 40:383–388
Rainsford KD (1977) Aspirin and gastric ulceration. Light and electronmicroscopic observations in a model of aspirin plus stress ulcerogenesis. Br J Exp Pathol 58:215–219
Rainsford KD (1981) Comparison of the gastric ulcerogenic activity of new non-steroid anti-inflammatory drugs in stressed rats. Br J Pharmacol 73:79–80
Rainsford KD (1978) Is the radiochromium red cell technique a valid method for measuring blood loss or damage following aspirin administration? Drugs Clin Res 4:183–189
Rainsford KD (1977) Towards assays of gastro-intestinal toxicity on non-steroid anti-inflammatory drugs with improved predictive value in man. Agents Actions 7:245–248
Rainsford KD (1978) Comparative studies of gastric ulcerogenesis by non-steroid anti-inflammatory drugs: Effects of fenclofenac. Proc R Soc Med (Suppl 6) 70:4–10
Rainsford KD (1979) Prostaglandins and the development of gastric mucosal damage by anti-inflammatory drugs. In: Rainsford KD, Ford-Hutchinson AW (eds) Prostaglandins and Inflammation. Birkhäuser, Basel, pp 193–210
Rainsford KD (1976) Gastric mucosal ulceration induced by tablets but not suspensions or solutions of aspirin in pigs. J Pharm Pharmacol 30:129–131
Rainsford KD, Peskar BM (1979) Relationship between gastric ulceration and mucosal prostaglandin concentrations following chronic oral administration of aspirin preparations to pigs. In: Brune K, Baggiolini M (eds) Arachidonic acid Metabolism in Inflammation and Thrombosis. Birkhäuser, Basel, pp 293–297
Rainsford KD, Peskar BM, Brune K (1981) Relationship between inhibition of prostaglandin production and gastric mucosal damage induced by anti-inflammatory drugs may depend on type of drugs and species. J Pharm Pharmacol 33:127–128
Bustad LK, McClelland (1966) Swine in Biomedical Research. US Atomic Energy Commision and Batelle Memorial Institute, Seattle, WA
Muggenburg BA, McNutt SH, Kowalczyk T (1964) Pathology of gastric ulcers in swine. Am J Vet Res 25:1354–1365
Huber WG, Wallin RF (1967) Pathogenesis of porcine gastric ulcers. Am J Vet Res 28:1455–1459
Norton L, Nolan P, Sales, JEL, Eisman B (1972) A swine stress ulcer model. Ann Surg 176:133–138
Lovgren O, Allander E (1965) Indomethacin and peptic ulcer. Br med J 1:996
Brooks PM, Buchanan WW (1976) Current management of rheumatoid arthritis. In: Buchanan WW, Dick WC (eds) Recent Advances in Rheumatology, vol 1, part II. Livingstone, Edinburgh London New York, pp 34–87
Roth JLA (1974) Drug-induced lesions. In: Bockus HL (ed) Gastrointerology, vol 1. Saunders, Philadelphia, pp 487–514
Stock C, Sarles H (eds) Alcohol and the digestive tract, vol 95. INSERM, Paris
Needham CD, Kyle J, Jones PF, Johnson SJ, Kerridge DF (1971) Aspirin and alcohol in gastro-intestinal haemorrhage. Gut 12:819–821
Falaye JM, Odutola TA (1978) The economic potential and the role of aspirin and alcohol ingestion in relation to haematemesis and malaena. Niger Med J 8:526–530
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rainsford, K.D. An analysis of the gastro-intestinal side-effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species. Rheumatol Int 2, 1–10 (1982). https://doi.org/10.1007/BF00541263
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00541263